We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Legal - or what?
  • Torys LLP
  • Canada, USA
  • April 17 2012

"How can you manage issues arising from regulations and legal requirements in different jurisdictions."


Considerations for medical device software companies entering the Canadian market
  • Torys LLP
  • Canada
  • July 25 2011

Canada has one of the world’s largest medical device markets, estimated at C$6 billion in 2010, with sales of almost C$3 billion taking place in Ontario


Amendments to the Patented Medicines (Notice of Compliance) Regulations now in force
  • Torys LLP
  • Canada
  • June 13 2008

On June 12, 2008, amendments to the Patented Medicines (Notice of Compliance) Regulations (commonly referred to as the “PM(NOC) Regulations”) came into force


Ontario companies doing business with hospitals may become subject to access-to-information requests
  • Torys LLP
  • Canada
  • April 6 2011

Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities


Producers to manage pharmaceuticals and sharps returned by consumers
  • Torys LLP
  • Canada
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force


Canada's approach to functional foods
  • Torys LLP
  • Canada
  • April 21 2010

Today’s diet- and health-conscious environment has led to a proliferation of functional food marketing claims that advertise the specific health-enhancing characteristics of a food product


Ontario court confirms generic drug manufacturers not entitled to unjust enrichment
  • Torys LLP
  • Canada
  • January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott


Is get-up gone in Canada?
  • Torys LLP
  • Canada
  • March 25 2010

The recent decision of the Federal Court of Canada in Apotex v. Registrar of Trademarks and Glaxo Group Limited (March 12, 2010) continues a line of cases that restricts the use of “get-up” (which refers to colour, shape of packaging, etc.) as a trademark in respect of prescription pharmaceutical products


Draft guidelines on subsequent entry biologics
  • Torys LLP
  • Canada
  • February 15 2008

Health Canada has released a draft guidance document titled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”


Canadian and U.S. regulation of functional food claims
  • Torys LLP
  • Canada, USA
  • October 12 2010

In today's health-conscious marketplace, functional food labelling has grown into a multibillion dollar industry